JP2012529451A5 - - Google Patents

Download PDF

Info

Publication number
JP2012529451A5
JP2012529451A5 JP2012514392A JP2012514392A JP2012529451A5 JP 2012529451 A5 JP2012529451 A5 JP 2012529451A5 JP 2012514392 A JP2012514392 A JP 2012514392A JP 2012514392 A JP2012514392 A JP 2012514392A JP 2012529451 A5 JP2012529451 A5 JP 2012529451A5
Authority
JP
Japan
Prior art keywords
solid
composition according
solid composition
fatty acid
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2012514392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012529451A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/003531 external-priority patent/WO2010142456A1/en
Publication of JP2012529451A publication Critical patent/JP2012529451A/ja
Publication of JP2012529451A5 publication Critical patent/JP2012529451A5/ja
Ceased legal-status Critical Current

Links

JP2012514392A 2009-06-11 2010-06-11 5−アミノレブリン酸を含む固体組成物 Ceased JP2012529451A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09251538.6 2009-06-11
EP09251538 2009-06-11
PCT/EP2010/003531 WO2010142456A1 (en) 2009-06-11 2010-06-11 Solid compositions comprising 5-aminolevulinic acid

Publications (2)

Publication Number Publication Date
JP2012529451A JP2012529451A (ja) 2012-11-22
JP2012529451A5 true JP2012529451A5 (enExample) 2013-08-15

Family

ID=42628133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514392A Ceased JP2012529451A (ja) 2009-06-11 2010-06-11 5−アミノレブリン酸を含む固体組成物

Country Status (18)

Country Link
US (1) US20120134921A1 (enExample)
EP (1) EP2440188A1 (enExample)
JP (1) JP2012529451A (enExample)
KR (1) KR20140014401A (enExample)
CN (1) CN102802612A (enExample)
AU (1) AU2010257752B2 (enExample)
BR (1) BRPI1011650A2 (enExample)
CA (1) CA2763837A1 (enExample)
CL (1) CL2011003115A1 (enExample)
CO (1) CO6480960A2 (enExample)
CR (1) CR20110649A (enExample)
MX (1) MX2011013069A (enExample)
NZ (1) NZ596946A (enExample)
PE (1) PE20120858A1 (enExample)
RU (1) RU2527328C2 (enExample)
SG (1) SG176687A1 (enExample)
WO (1) WO2010142456A1 (enExample)
ZA (1) ZA201108850B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013521251A (ja) * 2010-03-01 2013-06-10 フォトキュア エイエスエイ 美容組成物
DE102012105512A1 (de) * 2012-06-25 2014-04-24 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur verlängerten Freisetzung von Wirkstoffen
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
KR20150141958A (ko) * 2013-03-12 2015-12-21 어플라이드 바이오리서치, 인크. 개선된 약물 전달을 위한 킬레이트화 좌제
JP6588193B2 (ja) * 2014-07-31 2019-10-09 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップCapsugel Belgium NV カプセル製剤
US20170216146A1 (en) * 2014-07-31 2017-08-03 Capsugel Belgium Nv Capsule formulation
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
US9956426B2 (en) 2015-02-26 2018-05-01 Amol Punjabi Upconverting nanoparticles
AU2016372575B2 (en) 2015-12-17 2022-12-08 Photocure Asa Method of photodynamic therapy (PDT) for bladder cancer
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN105481946B (zh) * 2015-12-18 2019-05-21 浙江工商大学 5-氨基酮戊酸与3-羟基吡啶-4-酮的缀合物及其制备法和用途
US10744212B2 (en) 2016-03-14 2020-08-18 General Electric Company Topical application of nerve labeling dyes for image-guided surgery
GB2546128A (en) * 2016-09-28 2017-07-12 Photocure Asa Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
CN107434753A (zh) * 2017-07-26 2017-12-05 南京大学 5‑氨基乙酰丙酸及其衍生物的泡腾片及其制备方法
PH12020550124B1 (en) 2017-12-01 2024-05-24 Nat Ct Child Health & Dev Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3181062B2 (ja) * 1991-01-31 2001-07-03 帝國製薬株式会社 下部消化管崩壊経口製剤
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
CZ291132B6 (cs) * 1995-03-10 2002-12-11 Photocure Asa Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem
EP2127642A3 (en) * 1998-08-13 2010-02-24 Cima Labs, Inc. Microemulsions as solid dosage forms for oral administration
EP1184038B1 (en) * 1999-06-09 2005-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
TW577606U (en) * 2001-11-20 2004-02-21 Carry Computer Eng Co Ltd Improved structure of all-in-one silicon disk
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use

Similar Documents

Publication Publication Date Title
JP2012529451A5 (enExample)
RU2011150920A (ru) Твердые композиции, содержащие 5-аминолевулиновую кислоту
HRP20210686T1 (hr) Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom
JP2010518029A5 (enExample)
JP2004505105A5 (enExample)
JP2021185179A (ja) 固溶体組成物および心血管疾患における使用
CN1205641A (zh) 含一氧化二氮的止痛药、消炎药和解热药的给药介质及含有这样的介质和药物的药物组合物
JP2007538009A5 (enExample)
JP2015514104A5 (enExample)
WO2002089787A1 (en) Potentiation of therapeutic effects of fatty acids
BRPI0710611A2 (pt) composições farmacêuticas e seus usos
CN1528315A (zh) 治疗糖皮质素功能失调相关性精神病的方法
JP7210542B2 (ja) Ctイメージング用のヨウ素化脂肪酸のナノエマルジョン
CA2620274A1 (en) Methods for the treatment of senile dementia of the alzheimer's type
CA2534202A1 (en) Lipid glycerides for the treatment of neurodegenerative conditions involving demyelination
IL285353B2 (en) ct contrast material to detect calcification
JP2020529441A5 (enExample)
JP2020526485A5 (enExample)
US9364465B2 (en) Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes
AU2018343995B2 (en) Use of Nor-Ursodeoxycholic acid for reducing liver fat
CN111093704A (zh) 用于减少身体脂肪的前列环素受体激动剂
Nishimoto et al. RETRACTED: DL–/PO–phosphatidylcholine serves as a memory enhancer for normal healthy subjects
EP4493178A1 (en) Fibrate compositions for treating inflammation and neuroinflammation
HK40029663A (en) Prostacyclin receptor agonists for reduction of body fat
JPWO2021076847A5 (enExample)